Improved survival in patients with lymph node‐positive gastric cancer who received preoperative radiation
Authors:
Open Access
Abstract
BACKGROUND: Several trials have been conducted to determine the feasibility of preoperative radiotherapy (RT) for gastric cancer. However, the absolute benefit from radiotherapy remains to be defined. In this study, the authors examined the use of preoperative RT (Pre‐RT) and postoperative RT (PORT) in patients with gastric cancer from the Surveillance, Epidemiology, and End Results (SEER) database.METHODS: The overall survival of patients who had nonmetastatic, resected gastric cancer between 2000 and 2006 was analyzed from the SEER database. Kaplan‐Meier survival curves comparing Pre‐RT, PORT, and no RT (No‐RT) were analyzed using the log‐rank test. A multivariate analysis (MVA) was conducted using Cox proportional hazards regression.RESULTS: The authors identified 10,251 patients. There was no survival benefit for patients who received Pre‐RT or PORT compared with No‐RT patients for the entire cohort. Conversely, among lymph node‐positive patients, there was a significant survival benefit from both Pre‐RT and PORT compared with No‐RT (log‐rank test: PORT, P < .0001; Pre‐RT, P = .0261). The median survival and 5‐year overall survival among lymph node‐positive patients were 22 months and 24%, respectively, for Pre‐RT;29 months and 34%, respectively, for PORT; and 19 months and 20%, respectively, for No‐RT. MVA demonstrated that Pre‐RT, PORT, and removing ≥15 lymph nodes were independent predictors of improved survival, whereas tumor classification, lymph node status, tumor size, and tumor location were independent predictors of death.CONCLUSIONS: The current results supported the use of Pre‐RT in select patients with gastric cancer. However, additional trials will be needed to confirm these findings. Cancer 2011;. © 2011 American Cancer Society.Keywords
This publication has 18 references indexed in Scilit:
- The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature dataCancer Treatment Reviews, 2007
- Stage-Specific Effect of Adjuvant Therapy Following Gastric Cancer Resection: a Population-based Analysis of 4,041 PatientsAnnals of Surgical Oncology, 2007
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- Gastric Cancer — New Therapeutic OptionsNew England Journal of Medicine, 2006
- Gastic cancerThe Lancet, 2003
- Concentrated preoperative radiotherapy for resectable gastric cancer: 20‐years follow‐up of a randomized trialJournal of Surgical Oncology, 2002
- Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatmentAnnals of Surgical Oncology, 2002
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancerEuropean Journal of Surgical Oncology, 2000
- Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinomaSurgical Oncology, 1994